| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 30 Jan 2026 | 48 | 40% | 42% | 18% | 62% |
| 01 Jul 2024 - 31 Dec 2024 | 30 Jan 2025 | 44 | 47% | 39% | 14% | 60% |
| 01 Jan 2024 - 30 Jun 2024 | 01 Aug 2024 | 38 | 54% | 36% | 10% | 56% |
| 01 Jul 2023 - 31 Dec 2023 | 14 Feb 2024 | 42 | 39% | 45% | 16% | 67% |
| 01 Jan 2023 - 30 Jun 2023 | 02 Aug 2023 | 40 | 39% | 49% | 13% | 71% |
| 01 Jul 2022 - 31 Dec 2022 | 31 Jan 2023 | 64 | 24% | 45% | 31% | 85% |
| 01 Jan 2022 - 30 Jun 2022 | 03 Aug 2022 | 49 | 28% | 48% | 24% | 78% |
| 01 Jul 2021 - 31 Dec 2021 | 26 Jan 2022 | 41 | 46% | 38% | 17% | 62% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 39 | 40% | 49% | 12% | 68% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 43 | 24% | 64% | 12% | 79% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 40 | 43% | 37% | 20% | 43% |
| 01 Jun 2019 - 31 Dec 2019 | 31 Jan 2020 | 42 | 35% | 49% | 16% | 75% |
| 01 Jul 2018 - 31 Dec 2018 | 31 Jan 2019 | 36 | 36% | 59% | 5% | 33% |
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 | 36 | 36% | 59% | 5% | 33% |
| 01 Jul 2017 - 31 Dec 2017 | 31 Jan 2018 | 18 | 50% | 35% | 15% | 57% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
Standard payment terms are agreed with suppliers when they are set up on our systems before the first contract is entered into. The most commonly used payment terms are 30 days and the maximum is 60 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
N/A
Maximum contractual payment period agreed
60
Disputes are raised with the central accounts payable team who will assess whether the issue relates to price or quality of product and include the relevant teams in discussions with the supplier so that a resolution can be found.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
CLINIGEN LIMITED is a UK-based global pharmaceutical and services company that specializes in providing access to medicines and clinical trial services. The company was founded in 2010 and is headquartered in Burton-on-Trent, UK.
The company's main focus is providing access to critical medicines for patients in need, particularly in the areas of oncology, immunology, and rare diseases. They have a strong commitment to sustainability and have implemented various initiatives to reduce their environmental impact and promote social responsibility.
One of their key sustainability programs is their "Green Agenda" which aims to reduce their carbon footprint and promote sustainable practices throughout their operations. They have also implemented a waste management system to reduce waste and increase recycling.
CLINIGEN LIMITED offers a range of products and services including unlicensed medicines, clinical trial supply management, and support for pharmaceutical companies seeking regulatory approval for their products. These products and services are essential for patients who may not have access to licensed medicines or who are participating in clinical trials.
The company's key people include CEO Shaun Chilton and Chairman Peter George, who both have extensive experience in the pharmaceutical industry. They lead a team of over 1,500 employees across their global operations.
For more information on CLINIGEN LIMITED and their products and services, you can visit their website at www.clinigengroup.com. Their registered office address is Pitcairn House, Crown Square, First Avenue, Burton-on-Trent, Staffordshire, DE14 2WW, UK.
Proud of your payment record? Show your live score on your own site:
<iframe src="https://paymentcheck.co.uk/badge/06771928" width="240" height="72" style="border:0" title="PaymentCheck Score" loading="lazy"></iframe>